The Pharmaceutical Benefits Advisory Committee is pushing for greater transparency in its public summary documents and a shift in how it expresses an opinion on individual medicines.
PBAC: Public interest in knowing our view on 'each medicine being available'
July 1, 2019 Latest NewsLatest Video
New Stories
-
Stoking 'good' antibodies key to reducing serious bee venom allergic reactions
January 20, 2025 - - Australian Biotech -
'This is a world-leading approach to reduce the impact of RSV on babies'
January 20, 2025 - - Latest News -
New leadership for Boehringer Ingelheim as the company recognised as top employer
January 20, 2025 - - Latest News -
Christopher Luxon replaces health minister in push for faster progress on change
January 20, 2025 - - Latest News -
Make the institution and its nobility work for patients, not the other way around
January 16, 2025 - - Latest News -
Could this system's 'nobility' embrace a new idea, even if they recognised it?
January 15, 2025 - - Latest News -
Patients do not live their condition as aggregated economic models
January 14, 2025 - - Latest News